Point-of-Care Diagnosis of Acute Myocardial Infarction in Central Vietnam: International Exchange, Needs Assessment, and Spatial Care Paths : Point of Care

Secondary Logo

Journal Logo

Original Article

Point-of-Care Diagnosis of Acute Myocardial Infarction in Central Vietnam

International Exchange, Needs Assessment, and Spatial Care Paths

Kost, Gerald J. MD, PhD, MS, FAACC*†; Zadran, Amanullah BS, BA*†; Duong, Thuan T.B. MD, PhD; Pham, Tung T.; Ho, An V. D.; Nguyen, Nhan V. MD, PhD; Ventura, Irene J. BS*; Zadran, Layma BS*; Sayenko, Mykhaylo V. BS*; Nguyen, Kelly BS*

Author Information
Point of Care: The Journal of Near-Patient Testing & Technology 17(3):p 73-92, September 2018. | DOI: 10.1097/POC.0000000000000167

Abstract

Erratum

In an article that published in September 2018, the Open Access license type was incorrectly listed. The correct wording should be:

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

These corrections has been noted in the online version of the article, which is available at www.poctjournal.com.

Point of Care. 17(4):136, December 2018.

The long-term collaborative goal is national development of point-of-care (POC) culture, professional practice, and evidence-based decision making in Vietnam. Specific objectives for this research were (a) to compare needs assessment survey results in Vietnam currently versus 1 decade ago, (b) to determine hospital POC instrument and diagnostic capabilities in the regional districts of Thua Thien Hue Province (TTHP), and (c) to recommend designs, technologies, systems logic, algorithms, and Spatial Care Paths (SCPs) that accelerate the care of patients suspected of having acute myocardial infarction (AMI) in the health care small-world network (SWN) of Hue University Medical Center.

NATIONAL DEVELOPMENT

Following countrywide education programs in 2016 and 2017 (Table 1), our collaborative strategy for advancing point-of-need decision making in Central Vietnam comprised (a) producing an international symposium (Table 2) presented by local and international speakers (Fig. 1) and free for all who wished to attend; (b) conducting full-time field research on site for 1 month; (c) performing POC testing (POCT) needs assessment throughout TTHP; and (d) accelerating diagnosis to improve the care of AMI patients by implementing POC cardiac biomarker testing while optimizing regional SWNs. Surveys also addressed POCT for other medical challenges, such as molecular technologies for infectious diseases, outbreaks, and sepsis; test clusters for diabetes mellitus; and laboratory support of critically ill patients in isolation and intensive care.

T1
TABLE 1:
National Educational Program and POC Culture Development in Vietnam
T2
TABLE 2:
International Symposium Lectures—MųC LųC
F1
FIGURE 1:
International symposium speakers and research team in Hue. This figure can be viewed online in color at www.poctjournal.com.

BACKGROUND

Historical Perspective

Over a decade ago, one author in collaboration with country colleagues in Cambodia and Vietnam performed surveys1 of POCT sponsored by a Fulbright Scholar Award (to G.J.K.) for the development of POC culture in Association of Southeast Asian Nations (ASEAN) member states. The Fulbright was based out of Chulalongkorn University in Bangkok, Thailand. Upon surveying Cambodia at that time, we found no cardiac biomarker testing whatsoever. In Southern Vietnam, 33% of small hospitals surveyed1 performed exclusively creatine phosphokinase (CK) or CK-MB isoenzyme (CK-MB) testing in small laboratories to diagnose AMI, whereas none offered cardiac troponin (cTn) testing; 33% of medium-sized hospital laboratories performed qualitative cardiac troponin I (cTnI), and 33%, quantitative cardiac troponin T (cTnT) testing; and 25% of large hospitals performed either qualitative or quantitative cTnI, and 25%, quantitative cTnT testing. None of the sites surveyed offered cardiac biomarker testing at points of care (see Tables 2 and 3 in Kost et al1).

At the time of the previous survey, Vietnamese health systems lacked systematic means of quickly rescuing, diagnosing, and treating patients living in remote locations. No helicopter transport was available, and ambulance service was inadequate. We concluded, “Cost-effectiveness should be assessed in the context of complete cycles of care from home to hospital and back, for which POCT offers unique advantages in the diagnosis, triage, acute care, intensive care, bedside testing, and after discharge, monitoring at the primary care and home levels.”1 Further, “Critical care testing and POCT must become prominent components of public health strategies and infrastructures in this low-income country to improve acute care and disaster preparedness.”1 Now, cardiac deaths are increasing in Vietnam, in part attributed to late diagnosis,2 and more fundamentally, to the surprising increase in, and burden of, ischemic heart disease.3,4

New Mission

In 2014, the World Health Organization produced a Vietnam country profile of noncommunicable disease and associated mortality.5 Of approximately 91 million people, 33% of deaths were attributed to cardiovascular diseases alone. Thus, the current new mission for our joint program with Vietnam is (a) to improve the standard of care and outcomes for patients with AMI; (b) to do so with geographic and demographic equity, specifically targeting badly neglected rural regions in need; and (c) to direct diagnostic resources appropriately, efficiently, and cost-effectively.

EDUCATION AND TRAINING

Hypothesis

Our basic hypothesis is that education is fundamental to progress, progress is vital for social equity, and social equity is inherent in sustainable POC culture. We conducted a 2-year national POCT and acute coronary syndrome (ACS) lecture program in 2016 and 2017 comprising collaborative-cooperative instruction and shared experiences in the practice of point-of-need decision making and rapid response diagnostics.

We held lecture and training sessions in 3 key regions—Ho Chi Minh City (HCMC, the South), Hue (Central), and Hanoi (the North). These activities presaged our international exchange organized and supported by the Point-of-Care Testing Center for Teaching and Research (POCT•CTR) at the University of California, Davis (UC Davis), for TTHP, in collaboration with the Faculty of Hue University of Medicine and Pharmacy (HUMP).

International Symposium

Before the needs assessment field survey began, the POCT•CTR sponsored an International Symposium at HUMP with presentations given by (a) the leading Vietnamese POC coordinator, who works at French-Vietnam Hospital in HCMC, (b) guests invited from the United States and Taiwan, and (c) local HUMP expert speakers.

Three undergraduate students (K.N., M.V.S., and A.Z.) from UC Davis, received POCT•CTR travel-research funding, and one (A.Z.), a distinguished UC Davis Student Travel Award, to present at the symposium. Table 2 outlines the international symposium program, which provided a successful platform for launching collaborative regional research investigating the province health care SWN.

Shift to Primary Care

This long-term program was designed to progressively facilitate the implementation of POCT throughout Vietnam in line with recent central government emphasis on redirecting substantial health care funding to smaller community hospitals and primary care sites of first patient contact where diagnostic testing is needed urgently on a daily basis, in order to practice evidence-based medicine.

METHODS

Survey Scope

To determine the status of POCT and other diagnostics at 15 hospitals in 7 districts in TTHP, we surveyed hospital staff on site in both the Vietnamese and English languages. For consistency, we used newly prepared formal survey questionnaires. The province has a tropical monsoon climate, making it rainy and humid throughout the year. It borders Laos to the west. Districts closest to the border are mountainous, with very limited medical resources and extremely constrained access to health care. People living in mountainous regions tend to be culturally distinct and not well integrated with urban styles. To the east is the Bien Deng Sea, also known as the South China Sea. The costal peninsulas and other geographic features of the thin central region of Vietnam present their own challenges for north-south travel over high passes and expeditious cardiac care.

The province is made up of 9 district-level subdivisions comprising 6 districts (A Luoui, Nam Dong, Phong Dien, Phu Loc, Phu Vang, and Quang Dien), 2 towns (Huong Thuy and Huong Tra), and 1 provincial city, Hue, the ninth most populous in Vietnam. Further subdivided administrative units comprise 8 commune-level towns, 105 communes, and 39 wards. We surveyed 6 districts in the time permitted during 1 month on site. This collaborative research was followed by e-mail correspondence, teleconferences, and limited select field visits conducted by Vietnamese students to expand the base of district sites and clarify factual details.

Hospital Levels

Vietnamese hospitals are classified by the government into “levels” (Table 3). The most common is level 4, 1 per commune, with more than 150 in TTHP. These sites, historically and typically the least well equipped and poorest funded, also are known as community health centers. Level 3 hospitals, 1 per district, are commonly known as district hospitals. They are better equipped and funded than level 4 hospitals.

T3
TABLE 3:
Hospital Levels in Vietnam

There is 1 level 2 hospital per province, the provincial hospital, even better equipped and funded. Hue University Hospital is level 2. Hue Central Hospital is located in the provincial capitol and is one of the largest in Vietnam. It is 1 of only 3 level 1 hospitals, along with Bach Mai Hospital in Hanoi and Cho Ray Hospital in HCMC, in all of Vietnam. Administration of a level 1 hospital is tightly controlled by the central government. We did not survey the level 1 hospital. Our focus was on the regional health care SWN, mainly rural areas referring patients to higher-level hospitals.

Needs Assessment

We conducted POC needs assessment6 according to formal methods and statistical approaches developed during the course of our UC Davis Point-of-Care Testing Center funded by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, at the POCT•CTR. We published a series of articles summarized in the first chapter,7Needs Assessment for Rapid Decision Making in Pandemics, Complex Emergencies, and Disasters: A Global Perspective,” of Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience (Global Point of Care).

In Global Point of Care,8 the first Appendix provides an English survey tool that readers can adapt to their own settings and interests. Working from this platform,9 we customized a survey for Central Vietnam. The World Health Organization recently emphasized the importance of needs assessment as a first step in relation to determining purpose in “A Guide to Aid the Selection of Diagnostic Tests.”10 Our new English survey was translated into Vietnamese (Appendix 2, Supplemental Digital Content 2, https://links.lww.com/POC/A17) by 1 coauthor (T.T.B.D.) and piloted to improve fidelity of responses. Both this Vietnamese translation and the English version (Appendix 1, Supplemental Digital Content 1, https://links.lww.com/POC/A16) can be found in the appendices available online.

Geographic Information System, SWNs, and SCPs

Approaches to geographic and topographic analyses are described by Ferguson et al11,12 based on research conducted at the POCT•CTR. Small-world network theory and application are explained in “Using Small-World Networks to Optimize Preparedness, Response, and Resilience,” Chapter 49 in Global Point of Care.13 An SCP is defined as the most efficient route taken by the patient when receiving definitive care in an SWN.14 Background rationale, detailed explanation, SCP illustrations, and tabular summaries of impact can be found with free access at http://www.ifcc.org/media/332055/eJIFCC2014Vol25No2pp134-153.pdf.

POC Culture

The concept of POC culture (“the future of world medicine for individuals globally”) was created by 1 author (G.J.K.) in 2010 and summarized by Kost et al.15 Relevant survey questions regarding POC culture were based on Appendix 316 of Global Point of Care8 and on previous surveys conducted in Cambodia, Indonesia, the Philippines, Thailand, Vietnam, and other ASEAN member states.

Analysis and Statistics

Quantitative methods, associated publications, case illustrations, and needs assessment theory can be found in Chapter 1 of Global Point of Care.7 Briefly, survey respondents assigned ranks, Rj, with j = [1, nr], where nr is the number of possible ranks for each factor; Fi, where i = [1, nf]; and nf = the number of factors given for selection. Scores were calculated using the following equation: Sj = (nr + 1) − Rj.

We determined the weighted scores by summing the product of each score and the corresponding frequency as follows:

where the frequency, Fij, is the number of times survey respondents assigned an individual factor a specific rank. When a respondent designated the same rank for 2 or more factors (a “tie”), an average rank was assigned to each factor, and positions of factors with lower ranks were adjusted accordingly. Statistical methods are described by Kost et al.7

RESULTS

Tables 1 and 2 present the 2-year educational programs conducted in North, Central, and South Vietnam during 2016 and 2017. In 2017, we focused on Central Vietnam, because the preceding broad diagnostics surveys documented deficiencies of cardiac biomarker testing in this region, both at points of care and in hospital laboratories (Fig. 2). Table 4 and subsequent Tables 5–11 present survey results.

F2
FIGURE 2:
Status of POC and clinical laboratory cardiac biomarker testing in Vietnam. The left frame shows the status in 2016, whereas the right frame, 2017. This geographic information systems analysis of trends over the 2-year period of POCT national development shows that Central Vietnam remains deficient in both POC and clinical laboratory cTnT diagnostic resources. During the survey in TTHP, we found no POC cTnI testing, which generally was deficient in central and far north-south regions. This figure can be viewed online in color at www.poctjournal.com.
T4
TABLE 4:
Weighted Scores Identifying Needs Priorities for POC Diagnostic Tests*
T5
TABLE 5:
Demographics, Critical Care Resources, and Cardiac Biomarker Utilization in Central Vietnam Hospitals
T6
TABLE 6:
Site-Specific Deployment of POCT*
T7
TABLE 7:
POCT Emergency Medical Staff Should Perform While Transporting Patients in Order to Speed Up Treatment*
T8
TABLE 8:
Characterization of Emergency Services
T9
TABLE 9:
Strategic Diagnosis, POCT Availability, and Referral Patterns in Central Vietnam
T10
TABLE 10:
Acute Coronary Syndromes and Approaches to Patient Care in the Community
T11
TABLE 11:
Ambulance Services in TTHP Province

Table 4 reports the results of basic needs assessment. Overall, respondents favored key diagnostic test clusters for urgent care. The Pareto plot (Fig. 3) illustrates the results and indicates statistically significant differences in rankings. Top priorities were attached to hematology, pulse oximetry, chemistry/electrolytes/ionized calcium (Ca2+), blood gases, and rapid microbiology test clusters in the emergency room.

F3
FIGURE 3:
Pareto plot showing survey respondent priorities for diagnostic test clusters. The Pareto plot presents perceived priorities for diagnostic test clusters based on survey needs assessment. P values approximate levels of significant differences for the labeled test clusters versus hematology, the one ranked highest. Note that this graphic reflects what respondents stated is needed, not necessarily what is in place already. See Table 4 for additional details.

Despite the high prevalence of ACS in the province, cardiac biomarkers came in sixth. Coagulation tests and blood typing received the lowest overall weighted scores. However, cardiac biomarkers placed third after hematology and rapid microbiology tests at level 4 hospitals, which often provide the initial critical contact points for urgent cardiac care. Likewise, the level 2 hospital ranked cardiac biomarkers third, in this case after rapid microbiology and coagulation test clusters.

Table 5 summarizes demographics, critical care resources, and cardiac biomarker utilization in the hospitals surveyed. None of the sites reported vigorous POCT programs. The level 2 hospital offered both cTnT and cTnI testing. Neither cTn test was present in the other hospital levels, which depended mostly on electrocardiogram (ECG) for screening ACS patients. In the level 2 hospital, cTnT is performed on the Cobas 6000 system (Roche Diagnostics) and reimbursed by insurance. Emergency room staff in this hospital rarely ordered cTnI (none in the past year) because it was not covered by insurance. A cardiologist was available to which the other hospitals could refer patients, but we found no POC coordinators.

Table 6 reports site-specific deployment of POCT in community health centers, district hospitals, and the provincial hospital. Prehospital diagnosis of AMI in ambulances could alleviate the problem of obligatory transport of patients through the government-defined chain of different hospitals levels, which causes adverse delays, but none was found. We did find glucose meters in use. Table 7 presents the POC tests emergency medical staff felt should be performed while transporting patients, in order to speed up treatment, along with their rationale for use.

Tables 8 and 9 focus on the challenges of providing rapid response for patients with chest pain, no matter where they are at the time. Table 8 reports responses to specific survey questions. For question 3.2 (see the Appendices, Supplemental Digital Content 1 [https://links.lww.com/POC/A16] and Supplemental Digital Content 2 [https://links.lww.com/POC/A17]), respondents stated that ambulances did not function to rescue patients directly from homes, in some cases because of a shortage of ambulance-type vehicles.

In severe cases, patients could go directly to levels 1 and 2 hospitals with financial support, but for less severe cases, tiered partial payments incentivize patients to engage levels 4 > 3 > 2 > 1. Recently, patients have been allowed to skip level 4 and go to level 3 without financial penalty, but only if within their province of residence. A patient deemed a less severe case is penalized when going directly to level 1 or 2, because in that instance, insurance payment will not cover the full hospital costs.

From a public health standpoint, Table 9 justifies additional funding and the implementation of POC resources for patients with ACS, stroke, and hypertension, which would also facilitate the care of patients who present to the emergency room as a result of motor vehicle accidents, which occur most commonly among the young and middle aged.

Table 10 reflects the community approaches to patients suspected of having an AMI. For example, survey results revealed that severity dictates where patients seek help, as noted previously. However, without reliable ambulance service, the pathway to rescue is chaotic, frustrating, and time consuming. Responding to question 5.5, AMI was identified as the most common condition requiring referral to the larger hospitals in Hue City. Indeed, respondents reported that often AMI was untreated or not treated rapidly enough. For question 3.35, respondents wanted improved transportation systems, ambulances equipped with diagnostic technologies, enhanced screening, and training in resuscitation and cardiopulmonary resuscitation.

DISCUSSION

Past Versus Present Survey Results

Comparison of documented trends starting 12 years ago1 through 2016–2017 (Fig. 2) with current survey results reveals relatively modest progress in POC cardiac biomarker use throughout Vietnam. Vietnamese health care delivery systems would benefit from improved fundamental resources for the diagnosis, rapid transport, and treatment of critically ill patients, especially those presenting with ACS, in which case POC cTnI or cTnT could help rule in the diagnosis of AMI.

Role of POC Cardiac Biomarkers

Ruling out the diagnosis of AMI is limited by the low sensitivity of POC cTn assays. Therefore, temporal trends in cTn17 should be followed closely, and as necessary, high-risk patients transferred promptly. In rural areas, Minh18 recommended, “…evidence-based health interventions for reducing the burden of the cardiovascular disease epidemic in Vietnam….” Further, “Interventions should be comprehensive and integrated, including both primary and secondary approaches, as well as policy-level involvement.” In addition, biomarkers of heart failure, which are rising in importance in Asia, would facilitate differential diagnosis.19,20

A recent Asia Pacific consensus statement21 endorsed cardiac biomarker testing broadly, including high-sensitivity (hs) cTn, and stated, “…where only POCT is available, patients with elevated readings should be considered at high risk, while patients with low/undetectable readings should be retested after 6 hours or sent for laboratory testing… and regular education on the appropriate use of troponin tests is essential.” Contributors included 2 cardiology units in Vietnam, the Department of Cardiology at University Medical Center in HCMC and the National Cardiology Institute in Hanoi.

The consensus authors21 failed to point out, however, that current POC cTn tests cannot be used to rule out AMI because of low sensitivity. They focused on cTnI, whereas the POC cTn used commonly throughout Southeast Asia is cTnT. They did not comment on how POC cTnT can be partnered with laboratory-based hs-cTnT. These shortcomings must be rectified by additional work toward agreed practice standards, including for hs-cTnT when it appears in the clinical laboratories of Vietnam.

Technological Progress

Improved cardiac biomarker assays, such as the 9-minute hs-cTnT assay,22 the first hs-cTn test introduced in the United States that meets the International Federation of Clinical Chemistry and Laboratory Medicine guidelines and precision requirements under the third universal definition of AMI,23 should be implemented in Vietnamese hospital laboratories along with systematic approaches to rescuing rural patients with acute chest pain. Advances in assay speed enable faster therapeutic turnaround time, the time from ordering a test to treating the patient. Accelerated decision making fits one author's (G.J.K.) original vision 12 years ago24 illustrated as a paradigm shift of progressively faster cardiac biomarkers assays driving consensus standards of cardiac care.

As respondents reported, critical care infrastructure in Central Vietnam needs strengthening by simultaneously implementing whole-blood analyzers—handheld, portable, or transportable formats—for patients arriving at smaller hospitals, especially multiplex whole-blood analyzers with test clusters that include free calcium (“ionized calcium,” Ca2+) needed when stabilizing critically ill cardiac patients. Eventually, hs-cTn tests will appear on POC devices25 that allow both rule-in and rule-out of AMI, but for now POCT is best suited to ruling in the diagnosis when accompanied by characteristic history, symptoms, and signs, including ECG findings.

Value Proposition

The total costs for performing POCT, quality control, and proficiency testing must be weighed against benefits and alternatives by means of value propositions, as illustrated in Figure 4. Financial assistance can empower physicians and nurses in problem solving, local ownership, and sustainable enterprise. Current human resources and economic constraints, however, will not permit rapid improvement in Central Vietnam without substantial help from the central government, Ministry of Health, and foreign donors. In the United States, emergency rooms are experimenting with direct rapid physician evaluation in lieu of time-consuming triage,26 and in this regard, POC multiplex testing can be pivotal to rapid and efficient diagnosis in Central Vietnam.

F4
FIGURE 4:
Risk reduction value proposition for rapid response and improved outcomes. This figure can be viewed online in color at www.poctjournal.com.

Spatial Care Paths

Transport services, equipment, boats, and vehicles in the SWN of Hue University Hospital should be improved substantially, and in particular, coordinated SCPs must be designed and implemented so that the time to diagnosis and treatment is less than 1 hour. Spatial Care Paths help define the most efficient routes in TTHP for rescuing, diagnosing, and treating AMI patients rapidly. Figures 5 and 6 illustrate practical frameworks for solving the problem of limited access and prolonged time to treatment in challenging areas.

F5
FIGURE 5:
Spatial Care Path design for mountainous regions in TTHP. This figure can be viewed online in color at www.poctjournal.com.
F6
FIGURE 6:
Sequence of AMI patient progress in the coastal region. A, Conventional multistep patient evaluation and serial referrals triage involves serial patient steps in the coastal region near Hue in Central Vietnam. First, the patient travels by motorcycle or taxi from home to the level 4 hospital, then subsequently via boat and taxi to the level 3 hospital. Next, if warranted following evaluation, the patient transfers from the level 3 hospital to level 1 or level 2 hospital via ambulance. The sequential referral process is time consuming. B, Accelerated SCP with prehospital POC cTn diagnosis to reduce the number of steps taken, we recommend an efficient SCP for the coastal region near Hue. Diagnosis by means of POC cTn testing near the home or POCT available on an ambulance, along with telehealth ECG and bidirectional radio communication by a cardiologist, would permit the confirmed patient to skip the sequential steps and be transported directly from home to interventional care in the level 1 or level 2 hospital. Therapeutic turnaround time could be optimized. This figure can be viewed online in color at www.poctjournal.com.

Point-of-care cTn placements in hospitals of different levels and on ambulances can be optimized based on SCP designs explored further by local nurses, physicians, and health care SWN administrators. Table 11 summarizes ambulance services, which need to refocus efforts away from taxi-like functions and instead rescue patients with chest pain, particularly in rural inaccessible areas. Survey respondents stated that most (80%–90%) patients were transported by motorcycle or transported themselves to hospitals, obviously high risk.

Logistics prove as important as test characteristics, such as sensitivity, specificity, and predictive value, when ensuring high quality of diagnostic evidence at points of need in limited-resource settings. In conjunction with designing SCPs for the entire province, we recommend performing further SWN analysis, based on the principles established for limited-resource countries and their rural settings.27 In view of the high prevalence of cardiac disease in this province, rapid access to proven treatment via enhanced ambulance services combined with POC cTn testing will improve patient outcomes, cost-effectiveness, and equity of care for rural patients.

CONCLUSIONS

Needs Assessment

Based on demographic and geographic analyses of survey responses, resources for rapid diagnosis of AMI at points of care and in hospital laboratories performing cTn testing are lacking in Central Vietnam, similar to what appears to be the situation in the far north and far south (Fig. 2). All 3 regions have challenging topology subject to adverse weather encumbered by flooding and other natural disasters.

Lack of POC cardiac biomarker testing in the rural and mountainous areas of TTHP means that patient access and routing to swift interventional care for AMI are compromised even more so when transportation routes are blocked. Systems analysis provides strong indication for implementing POC cTn testing locally for diagnosis, triage, risk stratification, management, and prognosis of patients with suspected myocardial infarction.

International Exchange and Long-term Educational Impact

The 2-year education program was effective in highlighting the importance of cardiac biomarkers and their use at points of decision making. The second year saw direct interactive involvement of key opinion leaders and organizations, including the Center for Standardization & Quality Control in the Medical Laboratory in HCMC, the Vietnamese Association of Clinical Biochemists, and Hue University of Pharmacy and Medicine, where we held the 2017 International Symposium (Table 2). Participants learned how to use cTn assays to shorten visits to the emergency department, reduce the time to final diagnosis, manage non–ST-segment elevation myocardial infarction, and allow earlier safe discharge of low-risk subjects.28

POC Coordinators

Everyone recognized the critical need for training, deployment, and funding of POC coordinators throughout Vietnam, in order to implement POCT, ensure its quality, achieve accreditation (eg, ISO 22870), and facilitate future Ministry of Health policy, guidelines, and funding.

We suggest forming POC coordinator groups, similar to those that arose spontaneously during the early stages of the POC paradigm shift in the United States. These groups now meet regularly in person and/or via the Web (eg, see Internet-based lecture and audio POC coordinator programs at Whitehat Communications [https://whitehatcom.com/]).

Economic Burden and Cost-effectiveness

According to a recent (2017) report by American authors,29 “The HEART (History, ECG, Age, Risk factors, and initial Troponin) Pathway29–34 can be successfully implemented in a community hospital setting and achieve a meaningful reduction in the rate of admissions to the hospital for patients presenting with chest pain. The use of a simple, clinically meaningful computerized decision support tool was essential for good compliance… use of the pathway was associated with minimal major adverse cardiac events.” Nguyen et al35–37 stated, “The cost of AMI per hospitalization in Vietnam is higher than GDP per capita… AMI prevention is needed to reduce the burden of disease as well as to avoid catastrophic expenditure and impoverishment problems in Vietnam,” especially among women, who “…experience higher case fatality rates than men.”

Protocol-Based Practice

Current literature offers an international perspective of POC practice. Studies in the United States have demonstrated increasing use of cTnI/T and the 99th percentile threshold for the diagnosis of AMI.38 Others showed the practical utility of POC cTn for patients presenting to the emergency department.39,40 Japanese authors recently assessed the usefulness of POC cTn in the emergency department.41 A POC study conducted in an emergency department in Taiwan demonstrated the advantages of using multiple cardiac biomarkers to improve diagnosis of elderly and female patients,42 challenging groups for diagnosis, who would benefit in Vietnam.

Therefore, if validated for specific settings in Vietnam, algorithmic protocols, such as the HEART Pathway, with adaptations to merge POC decision making, will prove cost-effective for AMI patients and justify countrywide implementation of hs-cTn in clinical laboratories in partnership with POC cTn in emergency rooms in Vietnam. However, a definitive consensus protocol, with consideration of community settings29 and the potentially adverse impact of low-level cTn cutoffs on resource utilization,43 needs to be established specifically for Vietnam.

Health Care Resources

Health technology advisors recommend POC troponin testing for patients presenting with symptoms of ACS in settings with no immediate access to central laboratory testing.44–46 Appropriate use of POC assays will prove valuable during any central government redistribution of health care resources and in fact can become one of the primary modalities used to address acute care needs.

Cardiac biomarker testing in smaller hospitals (eg, levels 3 and 4) will serve larger numbers of patients consistent with demography and geography. Point-of-care cTn testing will fill service gaps in mountainous and coastal topographies, while facilitating more equitable cardiac care for diverse rural populations in Vietnam. Elderly ACS patients burdened with higher prevalence of risk factors, such as hypertension and diabetes mellitus,47 stand to benefit significantly.

Geographic Optimization

The analysis of travel times, ambulance routes, and telecommunication systems, ideally performed by means of POC geographic information system approaches,11,12 will reveal optimal sites for the placement of POC cardiac biomarker testing in emergency rooms with simultaneous consideration of routing of patients from homes and primary care sites to definitive intervention for coronary occlusion.

The coastal district represents a unique challenge for topographic analysis and SCP optimization. For example, a time-consuming leg of patient transport typically is by boat (Fig. 6). Helicopter transport would solve the problem. However, that resource generally is not available, so careful placement of POC cTn testing can be used to dynamically diagnosis AMI, that is, follow trends in cTn over the course of the prolonged transport and appropriately redirect to immediate intervention.

Province cardiologists should consider using prehospital diagnosis with POC cTn testing onboard ambulances in conjunction with telemetry of ECG and bidirectional telecommunication with cardiologists at referral sites.48,49 When relatively stable, patients could bypass intermediate levels 4 and 3 hospitals and be routed directly to levels 1 and 2 sites, where interventional cardiologists and adequate facilities, equipment, and medicinal supplies might be available.

Upstream SCP

Point-of-care testing embedded upstream closer to homes and sites of primary care and as mobile testing in ambulances allows SCPs to shift timely diagnosis and accelerate critical decision making for patients presenting with chest pain. The same principles apply to highly infectious diseases50–52 and other emergencies at points of need. In conjunction with POC coordinator guidance and oversight, this paradigm shift in accessibility to diagnosis and faster therapeutic response to acute medical challenges improves preparedness, sustainability, and resilience in the community.

Value of Physician Training

In limited-resource settings throughout Asia, we have encountered nurses who demand POC cTn testing to enhance decision making by young physicians assigned to remote emergency rooms and small hospitals, usually for 2 years of payback for government support of their medical education.

Point-of-care cTn provides crucial training, because these young graduates, typically working late hours by themselves, can use actual diagnostic evidence to practice their medical art, rather than guessing what is wrong with patients or placing patients in emergency room holding areas while waiting, too late, for a fatal condition to fully manifest.

Heretofore, the high value of POC cardiac biomarker testing for postgraduate education in remote limited-resource settings has been totally absent from studies of POCT cost-effectiveness. Physician training, per se, represents a critical role for POCT, an indispensible value hidden in plain sight.

FUTURE VISION

POC Culture

The international symposium in Vietnam provided a change agent for POC practice. Now engaged, professional attendees likely will initiate the type of cultural transformation seen in other Southeast Asian nations, such as Thailand. Following initial demonstration projects and symposia,27 POC cTnT was implemented in more than 500 Thai sites using 700 POC devices.

This innovation accelerated evidence-based diagnosis and therapeutic intervention for patients with AMI nationwide. Investigators in Vietnam can improve access, integrate algorithms, decrease overall costs, enhance education, and improve equity of care, especially in rural areas where geographic information systems analysis would prove highly beneficial for consistent deployment of resources.

Systems Logic

The Venn diagram (Fig. 7) captures the logic of future rapid chest pain evaluation by combining the upstream shift in POCT with state-of-the-art cTn assays integrated algorithmically (eg, using the HEART Pathway) to improve medical and economic outcomes in health care SWNs. With future technological progress (eg, see Florescu et al25 and Sarangadharan et al53), hs-cTn eventually will become available on handheld digital POC platforms.

F7
FIGURE 7:
Future logic synthesis for rapid intervention for acute chest pain. This figure can be viewed online in color at www.poctjournal.com.

The apparent discontinuity of the clinical laboratory (bottom left) versus points of need (bottom right) in Figure 7 will merge, advancing standards of care holistically throughout limited-resource communities. At the same time, mathematical models and geographic information systems can facilitate ambulance transport within the neglected areas of regional SWNs.54

National POCT Policy and Guidelines

We recommend that Vietnam establish national policy and guidelines, not only for the use and deployment of cardiac biomarkers, but also for POCT in general. Near neighbors, first Malaysia in 201255 and then Thailand in 2015,56 were successful in implementing suitable policy and guidelines (Figs. 8A, B).

F8
FIGURE 8:
National POCT policy and guidelines documents. A, Malaysia, 2012. B, Thailand, 2015. This figure can be viewed online in color at www.poctjournal.com.

One author (G.J.K.) has presented articles and been invited to speak in other countries, such as China, the Philippines, Singapore, South Africa, and Taiwan, to advance national guideline initiatives. Vietnamese government guidelines will provide a solid platform for funding, help harmonize POCT, facilitate collaboration, improve cooperation, and advance the standard of care for ACS patients.

Standards of Care

Policy should address regional cooperation among leading hospitals for cardiovascular care (eg, Ha Noi Heart Hospital, Cho Ray in HCMC, and Hue Central Hospital), satellite hospitals, and referral sites with linkages from home to intervention established through the design of efficient SCPs. Survey tools borrowed from the United States, for example, recently proposed by Hoa et al,57 are not adapted for the geography, topography, or settings of limited-resource countries. Adding needs assessment of POC and key test clusters to such survey tools will advance standards of primary care, responsiveness for patients who present with chest pain, and critical care support in Central Vietnam.

ASEAN Leadership

Forming a “critical mass” of countries in Southeast Asia with harmonized POCT policy and guidelines58 and avenues for bioinnovation59 would help codify the practice of POC cardiac biomarker testing, as well as creative use of POC technologies throughout ASEAN member states, leading to broad assimilation of POC culture.

Resulting direct evidence-based diagnosis will transform the care of patients with AMI, infectious diseases, and other urgent medical problems. Analogous to cTn-initiated improvements in the differential diagnosis of ACS patients historically, POC cTn in Central Vietnam will improve geographic accessibility, fill point-of-service gaps, and propel the quality of equitable care to higher regional standards with added community resilience.60

ACKNOWLEDGMENTS

The authors thank Dr Nam Tran, Pathology and Laboratory Medicine, UC Davis; Ms Jesse Lin, BS, MT(ASCP), EMBA, Taiwan National University, Taipei; and Dr Nguyen Thuy Loan Chi, POC coordinator at the French-Vietnamese Hospital, HCMC, for their invaluable presentations and contributions to the international symposium at Hue University.

The authors value discussions with Prof Nguyen Minh Tam, MD, PhD, head of the Office of Research and International Relations and chair of the Department of Family Medicine; Lecturer, Faculty of Public Health, HUMP.

The authors appreciate the enthusiasm and insights of Khun Artjana Uttaravichien (Regional Development Executive), Mr Ba Tong (Vietnam Marketing), and the other staff of Roche Diagnostics, both in Thailand and Vietnam, for their tireless and creative support of POC education and training in Southeast Asia.

The authors thank UC Davis and the Edward W. and Ora I. Kost Foundation for funding student research-travel awards and supporting the international symposium at HUMP. Figures and tables were provided courtesy and permission of Knowledge Optimization, Davis, CA.

REFERENCES

1. Kost GJ, Vansith K, Tuntideelert M. Critical care and point-of-care testing in Cambodia and Vietnam. Point of Care. 2006;5:193–198.
2. Than Nien News. Cancer, heart disease kills more in Vietnam due to late diagnosis, bad habits: experts. Hanoi, May 19, 2015. Available at: http://www.thanhniennews.com/health/cancer-heart-disease-kill-more-in-vietnam-due-to-late-diagnosis-bad-habits-experts-43489.html. Accessed April 3, 2018.
3. Institute for Health Metrics and Evaluation (University of Washington). GBD Profile: Vietnam. Seattle, WA: 2010. Available at: http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_country_report_vietnam.pdf. Accessed April 3, 2018.
4. Institute for Health Metrics and Evaluation (University of Washington) and the Human Development Network (The World Bank). The Global Burden of Disease: Generating Evidence, Guiding Policy—East Asia and Pacific Regional Edition. Seattle, WA: 2013. Available at: http://documents.worldbank.org/curated/en/758591468027855762/pdf/808500PUB0L2590Box0379820B00PUBLIC0.pdf. Accessed April 3, 2018.
5. World Health Organization (WHO). Noncommunicable Diseases (NCD) Country Profiles, 2014. Available at: http://www.who.int/nmh/countries/vnm_en.pdf?ua=1. Accessed April 3, 2018.
6. Weigl BH, Gaydos CA, Kost G, et al. The value of clinical needs assessments for point-of-care diagnostics. Point of Care. 2012;11:108–113.
7. Kost GJ, Louie RF, Truong AT, et al. Needs assessment for rapid decision making in pandemics, complex emergencies, and disasters: a global perspective. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:3–22, Chapter 1.
8. Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015.
9. Louie RF, Kost GJ. Clinical needs assessment survey. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:625–644, Appendix 1.
10. Kosack CS, Page AL, Klatser PR. A guide to aid the selection of diagnostic tests. Bull World Health Organ. 2017;95:639–645.
11. Ferguson WJ, Louie RF, Katip K, et al. Use of geographic information systems for the placement of point-of-care technologies in small-world networks. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:393–404, Chapter 35.
12. Ferguson WJ, Kemp K, Kost G. Using a geographic information system to enhance patient access to point-of-care diagnostics in a limited-resource setting. Int J Health Geogr. 2016;15:1–12.
13. Kost GJ. Using small-world networks to optimize preparedness, response, and resilience. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:539–568, Chapter 49.
14. Kost GJ, Ferguson WJ, Kost LE. Principles of point of care culture, the Spatial Care PathTM, and enabling community and global resilience. e-Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (e-JIFCC). 2014;25:134–153.
15. Kost GJ, Zhou Y, Katip P. Understanding of point-of-care culture improves resilience and standards of care in limited-resource countries. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:471–490, Chapter 43.
16. Kost GJ, Zhou Y, Katip P. Point of care culture survey. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:663–682, Appendix 3.
17. Curtis CM, Louie RF, Kost GJ. The current and future design of point of care in national disaster caches. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:413–432, Chapter 37.
18. Minh HV. Epidemiology of Cardiovascular Disease in Rural Vietnam. Umea International School of Public Health, Sweden, and Faculty of Public Health, Hanoi Medical University, Vietnam. Medical Dissertation No. 1018, 2006. Available at: https://www.diva-portal.org/smash/get/diva2:144495/FULLTEXT01.pdf. Accessed April 3, 2018.
19. Gaggin HK, Dang PV, Do LD, et al. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: the North South East West Trial. Clin Chem. 2014;60:758–764.
20. Richards AM. Biomarkers for heart failure in Asia. Heart Fail Clin. 2015;11:551–561.
21. Tan JWC, Lam CSP, Kasim SS, et al. Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI. Heart Asia. 2017;9:81–87.
22. Roche Diagnostics USA. Elecys troponin T Gen 5 STAT. Available at: https://usdiagnostics.roche.com/cardiac/troponin_sensitivity.html. Accessed April 3, 2018.
23. Sandoval Y, Smith SW, Apple FS. Present and future of cardiac troponin in clinical practice: a paradigm shift to high-sensitivity assays. Am J Med. 2016;129:354–365.
24. Kost GJ, Tran NK. Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers. Cardiol Clin. 2005;23:467–490.
25. Florescu O, Martin T, Cromer R, et al. Emerging low-cost digital testing at the point of need. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:173–176, Chapter 16.
26. Kincaid E. Innovations in Healthcare. How to fix the ER. Wall Street Journal. Wednesday, September 13, 2017, pp R1–R2. Available at: https://www.wsj.com/articles/how-to-fix-the-emergency-room-1505268780?mod=vocus&tesla=y. Accessed April 3, 2018.
27. Kost GJ, Kost LE, Suwanyangyuen A, et al. Emergency cardiac biomarkers and point-of-care testing: optimizing acute coronary syndrome care using small-world networks in rural settings. Point of Care. 2010;9:53–64.
28. Kozinski M, Krintus M, Kubica J, et al. High-sensitivity cardiac troponin assays: from improved analytical performance to enhanced risk stratification. Crit Rev Clin Lab Sci. 2017;54:143–172.
29. Smulowitz PB, Dizitzer Y, Tadiri S, et al. Impact of implementation of the HEART Pathway using an electronic clinical decision support tool in a community hospital setting. Am J Emerg Med. 2018;36(3):408–413. Available at: http://dx.doi.org/10.1016/j.ajem.2017.08.047. Accessed April 3, 2018.
30. Long B, Oliver J, Streitz M, et al. An end-user's guide to the HEART score and pathway. Am J Emerg Med. 2017;35(9):1350–1355.
31. Mahler SA, Stopyra JP, Apple FS, et al. Use of the HEART Pathway with high sensitivity cardiac troponins: a secondary analysis. Clin Biochem. 2017;50:401–407.
32. Riley RF, Miller CD, Russell GB, et al. Cost analysis of the History, ECG, Age, Risk factors, and initial Troponin (HEART) Pathway randomized control trial. Am J Emerg Med. 2017;35:77–81.
33. Yau AA, Nguyendo LT, Lockett LL, et al. The HEART Pathway and hospital cost savings. Crit Pathw Cardiol. 2017;16:126–128.
34. Hartman ND, Harper EN, Leppert LM, et al. A multidisciplinary self-directed learning module improves knowledge of a quality improvement instrument: the HEART Pathway. J Healthc Qual. 2018;40:e9–e14.
35. Nguyen HL, Ha DA, Phan DT, et al. Sex difference in clinical characteristics, hospital management practices, and in-hospital outcomes in patients hospitalized in a Vietnamese hospital with a first acute myocardial infarction. PLoS One. 2014;9(4):e95631.
36. Nguyen HL, Nguyen QN, Ha DA, et al. Prevalence of comorbidities and their impact on hospital management and short-term outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction. PLoS One. 2014;9(10):e108998.
37. Nguyen TP, Nguyen T, Pastma M. Economic burden of acute myocardial infarction in Vietnam (PCV88). Value in Health. 2015:18:A335–A766.
38. Hachey BJ, Kontos MC, Newby LK, et al. Trends in use of biomarker protocols for the evaluation of possible myocardial infarction. J Am Heart Assoc. 2017;6(9):1–7.
39. Juliano M, Wason C. Comparison of point-of-care versus laboratory troponin testing in an emergency department setting. Mil Med. 2017;182:e1938–e1940.
40. Wilke P, Masuch A, Fahron O, et al. Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department. PLoS One. 2017;12(11):e0188706.
41. Suzuki K, Komukai K, Nakata K, et al. The usefulness and limitations of point-of-care cardiac troponin measurement in the emergency department. Internal Medicine (Japanese Society of Internal Medicine). 2018;57(12):1673–1680. Accessed April 3, 2018.
42. Hung CL, Chien DK, Shih SC, et al. The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients: a clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan. BMC Cardiovasc Disord. 2016;16:191–197.
43. Becker BA, Stahlman BA, McLean N, et al. Low-level troponin elevations following a reduced troponin I cutoff: increased resource utilization without improved outcomes [published online ahead of print February 3, 2018]. Am J Emerg Med. 2018. DOI: 10.1016/j.ajem.2018.02.001.
44. Ho C, Cimon K, Jabr M, et al. Point-of-Care Cardiac Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome—Project Protocol. Ottawa, Ontario, Canada: CADTH; 2015. (CADTH Optimal Use Report vol.5, no.1a).
45. Ho C, Cimon K, Weeks L, et al. Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: A Health Technology Assessment. Ottawa, Ontario, Canada: CADTH; 2016. (CADTH optimal use report; vol.5, no.1b).
46. Ho C, Cimon K, Weeks L, et al. Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: Recommendations. Ottawa, Ontario, Canada: CADTH; 2016. (CADTH optimal use report; vol.5, no.1c).
47. Duc Cong N, Dung HT. The risk factors of acute coronary syndrome in patients over 65 years old at Thong Nhat Hospital of Ho Chi Minh City, Vietnam. J Atheroscler Thromb. 2014;21:S36–S41.
48. Claret PG, Bobbia X, Roger C, et al. Review of point-of-care testing and biomarkers of cardiovascular diseases in emergency and prehospital medicine. Acta Cardiol. 2015;70:510–515.
49. Sorensen JT, Stengaard C. Prehospital application of cardiac biomarkers for decision support in patients with suspected acute myocardial infarction. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:569–576, Chapter 50.
50. Kost GJ, Ferguson WJ, Hoe J, et al. The Ebola Spatial Care Path™: accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks. Am J Disaster Med. 2015;10:121–143.
51. Kost GJ, Ferguson W, Truong AT, et al. Molecular detection and point-of-care testing in Ebola virus disease and other threats: a new global public health framework to stop outbreaks. Expert Rev Mol Diagn. 2015;15:1245–1259.
52. Kost GJ. Point-of-care testing for Ebola and other highly infectious threats: principles, practice, and strategies for stopping outbreaks. In: Shephard M, ed. A Practical Guide to Global Point-of-Care Testing. Australia: CSIRO (Commonwealth Scientific and Industrial Research Organization); 2016:291–305, Chapter 24.
53. Sarangadharan I, Wang SL, Sukesan R, et al. Single drop whole blood diagnostics: portable biomedical sensor for cardiac troponin I detection. Anal Chem. 2018;90:2867–2874.
54. Tlili T, Abidi S, Krichen S. A mathematical model for efficient emergency transportation in a disaster situation [published online ahead of print January 29, 2018]. Am J Emerg Med. 2018. DOI: 10.1016/j.ajem.2018.01.039.
55. The Point of Care Testing Steering Committee. National Point of Care Testing Policy and Guidelines. Putrajaya, Malaysia: Ministry of Health Malaysia Medical Development Division, July 2012. Available at: http://moh.gov.my/images/gallery/Garispanduan/National_Point_of_Care_Testing.pdf. Accessed April 3, 2018.
56. Ministry of Public Health. Thailand's National Guidelines for Point-of-Care Testing (POCT). Bangkok: MOPH; 2015. Available at: http://blqs.dmsc.moph.go.th/assets/Userfile/POCTguideline.pdf. Accessed April 3, 2018.
57. Hoa NT, Tam NM, Peersman W, et al. Development and validation of the Vietnamese primary care assessment tool. PLoS One. 2018;13:e0191181.
58. Kost GJ, Baizurah bt MH. National point of care testing policy and guidelines in Malaysia, standards of care, and impact worldwide. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:505–610, Chapter 53.
59. Lin JC, Kost GJ. Bio-innovation in Taiwan, the first survey of point-of-care professional needs, and geospatially enhanced resilience in at-risk settings. Point of Care. 2017;16:78–88.
60. Kost GJ, Louie RF, Curtis C, et al. The logic web of community and global resilience. In: Kost GJ, Curtis CM, eds. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015:619–622, Chapter 55.
Keywords:

acute coronary syndrome (ACS); ambulance; cardiac troponin (cTn) I and T; district hospitals; evidence-based medicine (EBM); geographic information systems; hospital levels; Hue University of Medicine and Pharmacy (HUMP); needs assessment; point-of-care (POC) culture; prehospital diagnosis; primary care; small-world networks (SWNs); Thua Thien Hue Province (TTHP); value proposition

Supplemental Digital Content

Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc.